Class Action Filed Against Fermi Inc. Over IPO Period Disclosure Claims

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Class action filed against Fermi Inc. over false IPO disclosures regarding tenant demand and funding stability for Project Matador campus development.

Class Action Filed Against Fermi Inc. Over IPO Period Disclosure Claims

Levi & Korsinsky has initiated a class action securities lawsuit against Fermi Inc., targeting investors who purchased shares during the company's October 2025 initial public offering through December 11, 2025. The litigation alleges that Fermi made materially false statements regarding tenant demand for its Project Matador campus development and misrepresented the stability of a primary tenant's funding commitments.

According to the complaint, the company's disclosures to investors contained inaccuracies concerning both the market interest in the Project Matador property and the financial reliability of a key tenant's lease arrangement. These allegations suggest potential violations of securities laws pertaining to investor disclosures during the IPO period.

Investors who experienced losses on their Fermi Inc. holdings have until March 6, 2026, to file motions requesting lead plaintiff status in the case. The deadline represents a critical window for shareholders seeking to participate in the litigation or pursue potential recoveries related to their investment losses.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 19

Related Coverage

GlobeNewswire Inc.

Plug Power Faces Class Action Over DOE Loan Claims as April Deadline Looms

Plug Power faces class action lawsuit alleging false statements about DOE loans and hydrogen facilities. Investors have until April 3, 2026 to apply as lead plaintiffs.

PLUG
GlobeNewswire Inc.

BlackRock TCP Capital Hit by Class Action Over $19B NAV Collapse

BlackRock TCP Capital faces class action lawsuit after 19% NAV decline and 12.97% stock plunge. Investors must act by April 6 deadline.

TCPC
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
GlobeNewswire Inc.

Class Action Lawsuit Filed Against China Liberal Education Over Alleged $300M Pump-and-Dump Scheme

Class action lawsuit filed against China Liberal Education Holdings for alleged pump-and-dump scheme coordinating with scammers, resulting in $300M+ investor losses.

CLEUF
GlobeNewswire Inc.

METC Faces Class Action Over Brook Mine Claims; Lead Plaintiff Deadline Set for March 31

Ramaco Resources faces class action lawsuit over alleged false Brook Mine operational claims, with lead plaintiff deadline set for March 31, 2026.

METCMETCBMETCI
GlobeNewswire Inc.

Disc Medicine Stock Collapses on FDA Rejection; Law Firm Probes Securities Fraud

Pomerantz LLP investigates Disc Medicine ($IRON) for potential securities fraud after FDA rejected bitopertin drug application, triggering consecutive stock declines totaling over 28%.

IRON